TEOFARMA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 26,916 | 40,928 | 20,952 | 7,522 | 11,449 | 16,165 | 14,078 | 23,766 |
| Profit before tax | 1,551 | -4,937 | -11,373 | -21,906 | -2,261 | 969 | 1,881 | 4,765 |
| Net profit | 1,551 | -4,937 | -11,373 | -21,906 | -2,261 | 969 | 1,881 | 4,765 |
| Equity | -11,068 | -16,004 | -21,367 | -43,274 | -45,534 | -44,568 | -42,687 | -37,922 |
| Liabilities | - | 62,106 | 70,358 | 55,873 | 48,882 | 47,446 | 47,566 | 43,417 |
| Non-current assets | 25,383 | 13,278 | 13,545 | 11,339 | 1,134 | 1,400 | 567 | 1,114 |
| Current assets | 11,173 | 32,824 | 35,446 | 1,260 | 2,214 | 1,478 | 4,312 | 4,381 |
| Total assets | 36,556 | 46,102 | 48,991 | 12,599 | 3,348 | 2,878 | 4,879 | 5,495 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,504 | 2,259 | 4,031 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -31.6% | +52.1% | -48.8% | -64.1% | +52.2% | +41.2% | -12.9% | +68.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 4.2% | -10.7% | -23.2% | -173.9% | -67.5% | 33.7% | 38.6% | 86.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 5.8% | -12.1% | -54.3% | -291.2% | -19.7% | 6.0% | 13.4% | 20.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.8% | -12.1% | -54.3% | -291.2% | -19.7% | 6.0% | 13.4% | 20.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 9,228 | 11,162 | 6,984 | 4,867 | 11,449 | 16,165 | 14,078 | 20,370 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
TEOFARMA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-10-03 | 2026-10-04 | 405.51 |
| 2026-09-26 | 2026-09-28 | 405.51 |
| 2026-09-20 | 2026-09-21 | 499.36 |
| 2026-09-16 | 2026-09-17 | 499.36 |
| 2026-08-26 | 2026-09-02 | 436.49 |
| 2026-08-23 | 2026-08-25 | 507.88 |
| 2026-08-18 | 2026-08-19 | 507.88 |
| 2026-08-04 | 2026-08-17 | 8.09 |
| 2026-07-27 | 2026-08-03 | 507.45 |
| 2026-07-26 | 2026-07-26 | 499.36 |
| 2026-07-23 | 2026-07-25 | 507.45 |
| 2026-07-19 | 2026-07-22 | 499.36 |
| 2026-07-16 | 2026-07-17 | 499.36 |
| 2026-06-23 | 2026-07-06 | 415.07 |
| 2026-06-16 | 2026-06-22 | 498.94 |
| 2026-05-17 | 2026-06-03 | 506.05 |
| 2026-05-06 | 2026-05-14 | 6.26 |
| 2026-05-03 | 2026-05-05 | 498.88 |
| 2026-04-27 | 2026-04-29 | 498.88 |
| 2026-04-26 | 2026-04-26 | 492.62 |
| 2026-04-24 | 2026-04-25 | 498.88 |
| 2026-04-20 | 2026-04-23 | 499.36 |
| 2026-03-30 | 2026-04-01 | 297.65 |
| 2026-03-29 | 2026-03-29 | 490.55 |
| 2026-03-27 | 2026-03-27 | 498.52 |
| 2026-03-25 | 2026-03-26 | 490.55 |
| 2026-03-17 | 2026-03-24 | 498.52 |
| 2026-02-26 | 2026-03-03 | 461.32 |
| 2026-02-18 | 2026-02-25 | 499.36 |
| 2026-01-26 | 2026-02-03 | 449.00 |
| 2026-01-21 | 2026-01-25 | 450.66 |
| 2026-01-16 | 2026-01-20 | 449.20 |
| 2025-11-18 | 2025-11-27 | 231.94 |
| 2025-11-07 | 2025-11-17 | 2.40 |
| 2025-10-27 | 2025-11-06 | 74.00 |
| 2025-10-26 | 2025-10-26 | 71.60 |
| 2025-10-24 | 2025-10-25 | 74.00 |
| 2025-10-23 | 2025-10-23 | 231.57 |
| 2025-10-16 | 2025-10-22 | 229.17 |
| 2025-09-16 | 2025-09-23 | 228.41 |
| 2025-08-31 | 2025-09-03 | 153.23 |
| 2025-08-28 | 2025-08-29 | 233.04 |
| 2025-08-27 | 2025-08-27 | 153.23 |
| 2025-08-19 | 2025-08-26 | 233.04 |
| 2025-07-31 | 2025-08-18 | 3.50 |
| 2025-07-28 | 2025-07-30 | 186.30 |
| 2025-07-26 | 2025-07-27 | 182.80 |
| 2025-07-24 | 2025-07-25 | 186.30 |
| 2025-07-16 | 2025-07-23 | 228.41 |
| 2025-06-26 | 2025-07-06 | 207.88 |
| 2025-06-17 | 2025-06-25 | 228.79 |
| 2025-06-03 | 2025-06-03 | 43.81 |
| 2025-05-27 | 2025-06-02 | 159.81 |
| 2025-05-16 | 2025-05-26 | 232.58 |
| 2025-05-05 | 2025-05-15 | 3.79 |
| 2025-05-04 | 2025-05-04 | 226.46 |
| 2025-04-30 | 2025-04-30 | 228.41 |
| 2025-04-25 | 2025-04-29 | 226.46 |
| 2025-04-24 | 2025-04-24 | 232.20 |
| 2025-04-16 | 2025-04-23 | 228.41 |
| 2025-03-26 | 2025-04-06 | 223.68 |
| 2025-03-18 | 2025-03-25 | 228.41 |
| 2025-02-26 | 2025-03-06 | 220.67 |
| 2025-02-18 | 2025-02-25 | 229.17 |
| 2025-01-24 | 2025-02-10 | 203.60 |
| 2025-01-22 | 2025-01-23 | 206.55 |
| 2025-01-16 | 2025-01-21 | 202.98 |
| 2025-01-02 | 2025-01-06 | 201.98 |
| 2024-12-22 | 2024-12-31 | 201.98 |
| 2024-12-17 | 2024-12-20 | 203.31 |
| 2024-11-27 | 2024-12-04 | 205.95 |
| 2024-11-18 | 2024-11-26 | 207.26 |
| 2024-11-06 | 2024-11-17 | 2.93 |
| 2024-10-24 | 2024-11-05 | 205.64 |
| 2024-10-16 | 2024-10-23 | 203.65 |
| 2024-09-26 | 2024-09-29 | 201.46 |
| 2024-09-17 | 2024-09-25 | 203.65 |
| 2024-08-19 | 2024-08-27 | 207.33 |
| 2024-08-09 | 2024-08-18 | 3.00 |
| 2024-07-24 | 2024-08-08 | 189.45 |
| 2024-07-16 | 2024-07-23 | 202.98 |
| 2024-06-28 | 2024-07-01 | 54.32 |
| 2024-06-18 | 2024-06-27 | 204.00 |
| 2024-05-24 | 2024-06-05 | 202.23 |
| 2024-05-16 | 2024-05-23 | 208.52 |
| 2024-05-03 | 2024-05-15 | 4.87 |
| 2024-04-24 | 2024-05-02 | 182.68 |
| 2024-04-23 | 2024-04-23 | 208.18 |
| 2024-04-16 | 2024-04-22 | 203.31 |
| 2024-03-18 | 2024-04-02 | 203.31 |
| 2024-02-19 | 2024-03-04 | 371.96 |
| 2024-02-05 | 2024-02-18 | 167.96 |
| 2024-01-24 | 2024-02-04 | 175.82 |
| 2024-01-23 | 2024-01-23 | 188.29 |
| 2024-01-16 | 2024-01-22 | 184.53 |
| 2023-12-22 | 2023-12-28 | 182.25 |
| 2023-12-18 | 2023-12-21 | 184.84 |
| 2023-11-21 | 2023-12-04 | 183.07 |
| 2023-11-16 | 2023-11-20 | 190.94 |
| 2023-11-09 | 2023-11-15 | 5.49 |
| 2023-10-30 | 2023-11-08 | 277.19 |
| 2023-10-26 | 2023-10-29 | 271.70 |
| 2023-10-25 | 2023-10-25 | 277.19 |
| 2023-10-17 | 2023-10-24 | 271.70 |
| 2023-10-06 | 2023-10-16 | 86.56 |
| 2023-09-18 | 2023-10-05 | 260.97 |
| 2023-09-06 | 2023-09-17 | 75.52 |
| 2023-08-17 | 2023-09-05 | 316.53 |
| 2023-08-16 | 2023-08-16 | 131.69 |
| 2023-07-26 | 2023-08-15 | 181.63 |
| 2023-07-24 | 2023-07-25 | 181.70 |
| 2023-07-21 | 2023-07-23 | 178.50 |
| 2023-07-18 | 2023-07-20 | 185.45 |
| 2023-06-21 | 2023-07-02 | 182.67 |
| 2023-06-16 | 2023-06-20 | 185.45 |
| 2023-05-16 | 2023-05-24 | 265.21 |
| 2023-05-11 | 2023-05-15 | 80.68 |
| 2023-05-02 | 2023-05-10 | 190.35 |
| 2023-04-27 | 2023-04-28 | 190.35 |
| 2023-04-26 | 2023-04-26 | 185.76 |
| 2023-04-25 | 2023-04-25 | 190.35 |
| 2023-04-18 | 2023-04-24 | 185.76 |
| 2023-03-16 | 2023-03-21 | 400.89 |
| 2023-03-01 | 2023-03-15 | 216.36 |
| 2023-02-17 | 2023-02-28 | 348.87 |
| 2023-02-06 | 2023-02-16 | 163.42 |
| 2023-01-23 | 2023-02-03 | 163.42 |
| 2023-01-20 | 2023-01-22 | 158.06 |
| 2023-01-17 | 2023-01-19 | 160.90 |
| 2022-12-28 | 2023-01-11 | 325.79 |
| 2022-12-16 | 2022-12-27 | 325.92 |
| 2022-11-21 | 2022-12-15 | 165.29 |
| 2022-11-17 | 2022-11-18 | 165.29 |
| 2022-10-31 | 2022-11-16 | 4.39 |
| 2022-10-18 | 2022-10-27 | 367.53 |
| 2022-10-03 | 2022-10-17 | 206.36 |
| 2022-09-16 | 2022-10-02 | 322.14 |
| 2022-08-23 | 2022-09-15 | 160.97 |
| 2022-07-25 | 2022-08-22 | 0.34 |
| 2022-07-18 | 2022-07-21 | 158.86 |
| 2022-06-21 | 2022-07-14 | 142.31 |
| 2022-06-16 | 2022-06-20 | 159.13 |
| 2022-05-25 | 2022-05-30 | 152.09 |
| 2022-05-17 | 2022-05-24 | 155.76 |
| 2022-04-19 | 2022-04-21 | 161.17 |
| 2022-03-22 | 2022-04-03 | 156.81 |
| 2022-03-17 | 2022-03-21 | 160.37 |
| 2022-03-16 | 2022-03-16 | 312.80 |
| 2022-03-01 | 2022-03-15 | 152.43 |
| 2022-02-17 | 2022-02-28 | 195.83 |
| 2022-02-09 | 2022-02-16 | 34.93 |
| 2022-01-28 | 2022-02-08 | 334.93 |
| 2022-01-18 | 2022-01-27 | 277.66 |
| 2022-01-12 | 2022-01-17 | 135.92 |
| 2021-12-27 | 2022-01-11 | 1435.92 |
| 2021-12-10 | 2021-12-26 | 1153.14 |
| 2021-11-23 | 2021-12-09 | 2153.14 |
| 2021-11-19 | 2021-11-22 | 2130.33 |
| 2021-11-03 | 2021-11-18 | 2630.33 |
| 2021-10-18 | 2021-11-02 | 2843.55 |
| 2021-09-21 | 2021-10-17 | 2701.81 |
TEOFARMA - VMI tax arrears
As of 2026-10-07, the amount of overdue STI tax debt of the company TEOFARMA is: 1,584 €
| From | To | Overdue, € |
|---|---|---|
| 2026-10-01 | 2026-10-07 | 1584.1 |
| 2026-09-28 | 2026-09-30 | 1583.53 |
| 2026-09-04 | 2026-09-27 | 1541.53 |
| 2026-09-01 | 2026-09-03 | 2004.4 |
| 2026-08-28 | 2026-08-31 | 2001.37 |
| 2026-08-02 | 2026-08-27 | 1864.37 |
| 2026-07-09 | 2026-08-01 | 1541.59 |
| 2026-07-01 | 2026-07-08 | 1768.19 |
| 2026-06-28 | 2026-06-30 | 1767.89 |
| 2026-06-05 | 2026-06-27 | 1541.65 |
| 2026-06-01 | 2026-06-04 | 1764.37 |
| 2026-05-28 | 2026-05-31 | 1764.01 |
| 2026-05-12 | 2026-05-27 | 1542.01 |
| 2026-05-07 | 2026-05-11 | 1541.53 |
| 2026-05-01 | 2026-05-06 | 1840.17 |
| 2026-04-30 | 2026-04-30 | 1839.93 |
| 2026-04-24 | 2026-04-29 | 1541.93 |
| 2026-04-03 | 2026-04-23 | 1541.77 |
| 2026-04-01 | 2026-04-02 | 1839.42 |
| 2026-03-29 | 2026-03-31 | 1838.94 |
| 2026-03-27 | 2026-03-28 | 1678.31 |
| 2026-03-24 | 2026-03-26 | 7268.35 |
| 2026-03-20 | 2026-03-23 | 7358.22 |
| 2026-03-11 | 2026-03-19 | 0.09 |
| 2026-03-02 | 2026-03-10 | 1788.2 |
| 2026-02-09 | 2026-03-01 | 1678.11 |
| 2026-02-03 | 2026-02-08 | 1888.39 |
| 2026-01-30 | 2026-02-02 | 1888.14 |
| 2026-01-29 | 2026-01-29 | 1933.6 |
| 2026-01-16 | 2026-01-28 | 1723.6 |
| 2026-01-08 | 2026-01-15 | 1723.24 |
| 2026-01-01 | 2026-01-07 | 1951.95 |
| 2025-12-22 | 2025-12-31 | 1723.83 |
| 2025-12-19 | 2025-12-21 | 1723.52 |
| 2025-12-05 | 2025-12-18 | 1768.98 |
| 2025-12-01 | 2025-12-04 | 2067.53 |
| 2025-11-28 | 2025-11-30 | 2067.13 |
| 2025-11-18 | 2025-11-27 | 1769.13 |
| 2025-11-14 | 2025-11-17 | 1950.95 |
| 2025-11-08 | 2025-11-13 | 1950.6 |
| 2025-11-07 | 2025-11-07 | 2136.93 |
| 2025-11-02 | 2025-11-06 | 2227.84 |
| 2025-10-30 | 2025-11-01 | 2227.64 |
| 2025-10-15 | 2025-10-29 | 2041.64 |
| 2025-10-02 | 2025-10-14 | 2171.01 |
| 2025-09-28 | 2025-10-01 | 2170.86 |
| 2025-09-14 | 2025-09-27 | 2041.86 |
| 2025-09-11 | 2025-09-13 | 2132.77 |
| 2025-09-06 | 2025-09-10 | 2132.52 |
| 2025-09-01 | 2025-09-05 | 2333.0 |
| 2025-08-28 | 2025-08-31 | 2332.7 |
| 2025-08-14 | 2025-08-27 | 2132.7 |
| 2025-08-08 | 2025-08-13 | 2314.52 |
| 2025-08-02 | 2025-08-07 | 2314.46 |
| 2025-07-28 | 2025-08-01 | 2555.52 |
| 2025-07-13 | 2025-07-27 | 2314.52 |
| 2025-07-11 | 2025-07-12 | 2314.24 |
| 2025-07-08 | 2025-07-10 | 2405.15 |
| 2025-07-01 | 2025-07-07 | 2572.29 |
| 2025-06-28 | 2025-06-30 | 2570.88 |
| 2025-06-07 | 2025-06-27 | 2408.88 |
| 2025-06-05 | 2025-06-06 | 2499.79 |
| 2025-06-04 | 2025-06-04 | 2884.09 |
| 2025-06-02 | 2025-06-03 | 3901.71 |
| 2025-05-29 | 2025-06-01 | 3897.78 |
| 2025-05-01 | 2025-05-28 | 2808.78 |
| 2025-04-28 | 2025-04-30 | 2808.3 |
| 2025-04-24 | 2025-04-27 | 2496.3 |
| 2025-04-08 | 2025-04-23 | 2587.21 |
| 2025-04-07 | 2025-04-07 | 2746.41 |
| 2025-04-02 | 2025-04-06 | 2746.21 |
| 2025-03-28 | 2025-04-01 | 2745.83 |
| 2025-03-08 | 2025-03-27 | 2586.83 |
| 2025-03-02 | 2025-03-07 | 2672.97 |
| 2025-02-28 | 2025-03-01 | 2672.91 |
| 2025-02-17 | 2025-02-27 | 2586.91 |
| 2025-02-12 | 2025-02-16 | 2586.81 |
| 2025-02-02 | 2025-02-11 | 2619.42 |
| 2025-01-30 | 2025-02-01 | 2619.38 |
| 2025-01-23 | 2025-01-29 | 2587.38 |
| 2025-01-08 | 2025-01-22 | 2586.89 |
| 2025-01-01 | 2025-01-07 | 2864.33 |
| 2024-12-30 | 2024-12-31 | 2862.97 |
| 2024-12-20 | 2024-12-29 | 2745.97 |
| 2024-12-08 | 2024-12-19 | 2791.43 |
| 2024-12-06 | 2024-12-07 | 2788.43 |
| 2024-12-03 | 2024-12-05 | 2696.31 |
| 2024-11-28 | 2024-12-02 | 2696.21 |
| 2024-11-23 | 2024-11-27 | 2634.21 |
| 2024-11-22 | 2024-11-22 | 2725.12 |
| 2024-11-08 | 2024-11-21 | 2724.16 |
| 2024-10-01 | 2024-11-07 | 2799.87 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
TEOFARMA, UAB (code 135815688) is a Private Limited Liability Company engaged in business and other management consultancy activities. In 2025, the company generated revenue of €23.8K, up 68.8% year on year, and recorded net profit of €4.8K. The profit margin improved to 20.1%, compared with 13.4% in 2024 and 6.0% in 2023, indicating a clear strengthening of profitability over the last three years. Revenue moved from €16.2K in 2023 to €14.1K in 2024 and then increased sharply in 2025, while net profit rose from €969 to €1.9K and then to €4.8K over the same period. At the end of 2025, total assets stood at €5.5K, equity remained negative at €37.9K, and liabilities were €43.4K. Long-term assets were €1.1K and short-term assets €4.4K. The company’s asset turnover was 4.33x, and revenue per employee was €23.8K, with profit per employee of €4.8K. The negative equity position continues to weigh on balance sheet strength despite the improved operating performance.